[1]
B. Salustio Pires, J. Bratke, J. do Nascimento Santos Costa, M. de Souza Nars, and M. F. Mussolino Ribeiro, “Access to the population, financing and availability times of antineoplastic drugs incorporated into the SUS between 2012 and 2024”, J Assist Farm Farmacoecon, vol. 10, no. 2, May 2025.